7WD-22667-53316
2 vaccinations
5 coded responses
11 check-ins
5 free-text entries
4 call cases
- Sex
- Male
- Age at first dose
- 36-40
- ZIP prefix
- 781 / TX
- Registered
- 2021-01-19
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Dose 1 — Pfizer-BioNTech
-
2021-01-19
Registered in v-safe
-
2021-01-19
Survey response — day 21, dose 1MedDRA: Pain, Sensory disturbance — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Forced and painful push of blood through my blood vessels especially near the chest area and in my head.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-21
Dose 2 — Pfizer-BioNTech
-
2021-01-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Itching · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitAdult check-in
-
2021-01-25
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-01-30
-
2021-02-04
Survey response — day 14, dose 2MedDRA: Fatigue, Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Worse headache that combines with extreme tiredness.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-14
- 2021-02-27
-
2021-03-04
Survey response — day 42, dose 2MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Frequent headachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-04
Report sent to call center — day 42, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-05
Call successfulParticipant prefers to complete VAERS report online
-
2021-04-22
Survey response — 3 months, dose 2MedDRA: Chest pain, Dizziness, Dyspnoea exertional, Headache, Vision blurred — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Unending headache (like a constant hammer hitting my head), stubbing pain on my right side of chest, shortness of breath after walking short distances or walking up the stairs, dizziness and blurry vision.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-22
- 2021-11-06
- 2021-11-11
-
2022-01-23
Survey response — 12 months, dose 2MedDRA: Blood glucose increased, COVID-19, Feeling abnormal — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: COVID-19 Was in really bad health and blood sugars were high.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-23
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-01-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-21 | Pfizer-BioNTech |
Call center
4 call center cases
1 successful · 3 unsuccessful
1 wait over 3 months for a first call
Free text
Release 2 — day 21, dose 1
Symptoms: Forced and painful push of blood through my blood vessels especially near the chest area and in my head.
Release 3 — day 14, dose 2
Symptoms: Worse headache that combines with extreme tiredness.
Release 5 — day 42, dose 2
Symptoms: Frequent headaches
Release 7 — 3 months, dose 2
Symptoms: Unending headache (like a constant hammer hitting my head), stubbing pain on my right side of chest, shortness of breath after walking short distances or walking up the stairs, dizziness and blurry vision.
Release 11 — 12 months, dose 2
Symptoms: COVID-19 Was in really bad health and blood sugars were high.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blood glucose increased | · | · | ✓ |
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Dyspnoea exertional | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Feeling abnormal | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Sensory disturbance | ✓ | ✓ | ✓ |
| SD | Vision blurred | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release